StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) stock

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)

Close on Nov 17, 2026Market cap $4.72MP/E –Yield –

Intelligent Bio Solutions total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Intelligent Bio Solutions's total debt was $150.43K at Mar 31, 2024. For fiscal 2023 it was $402.86K.

Annual total debt

PeriodPeriod endValueChange
FY2023Jun 30, 2023$402.86K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2024CQ1 2024Mar 31, 2024$150.43K-68.1%
Q2 FY2024CQ4 2023Dec 31, 2023$230.97K-54.5%
Q1 FY2024CQ3 2023Sep 30, 2023$306.23K–
Q4 FY2023CQ2 2023Jun 30, 2023$402.86K–
Q3 FY2023CQ1 2023Mar 31, 2023$470.87K–
Q2 FY2023CQ4 2022Dec 31, 2022$507.40K–

More Intelligent Bio Solutions figures

See a number that looks wrong?